Poland· PL-100519667

DALZIOR Plus

A sitagliptin und dapagliflozin product containing sitagliptinum + dapagliflozinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC A10BD29

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDALZIOR PlusATCA10BD29REGISTER NO.PL-100519667PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Sitagliptin und dapagliflozin is registered in 5 of 19 countries.

Countries holding a registration under ATC A10BD29 (sitagliptin und dapagliflozin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Sitagliptin und dapagliflozin · ATC A10BD29

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Sitagliptinum + Dapagliflozinum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
A10BD29
ATC class
Sitagliptin und Dapagliflozin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05908289660746
  • gtin
    05908289660753

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sitagliptin und dapagliflozin in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sitagliptin und dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Sitagliptin/Dapagliflozin Ratiopharm, Sitagliptin/Dapagliflozin Tad
  • Belgium · Dibaglep
  • Bulgaria · Даградуо, Далзиор S Комбо
  • Cyprus · Gludapsi, Sitagliptin/Dapagliflozin Tad
  • Czechia · Dagrafors Duo
  • Germany · Dagraduo, Dapasitazin
  • Estonia · Dagraduo, Sitagliptin/Dapagliflozin Teva
  • Finland · Dagraduo
  • Greece · Dagraduo, Dapsita
  • Croatia · Daglyfy, Dagraduo
  • Hungary · Dagrafors Duo
  • Lithuania · Axigalu
  • Luxembourg · Dibaglep
  • Latvia · Daplussi, Sitagliptin/Dapagliflozin Teva
  • Malta · Gludapsi
  • Portugal · Dagraduo
  • Romania · Dagraduo, Dibaglep
  • Sweden · Ermegisto, Sidaglya
  • Slovenia · Daplussi
  • Slovakia · Dagraduo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/45643683-22a1-48ae-8eb1-bf1dedd9c034
GET /v1/drugs/45643683-22a1-48ae-8eb1-bf1dedd9c034?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "100 mg + 10 mg",
  "packaging": "05908289660746 ¦ Rp ¦ 166469\n30 tabl.\n05908289660753 ¦ Rp ¦ 166470\n60 tabl.",
  "substance": "Sitagliptinum 100 mg + Dapagliflozinum 10 mg",
  "common_name": "Sitagliptinum + Dapagliflozinum",
  "pl_product_id": "100519667",
  "pozwolenie_nr": "29510",
  "auth_procedure": "DCP",
  "authorisation_validity": "2031-03-30"
}

See everything about sitagliptin und dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.